What Katalyst Diagnostics does

Katalyst Diagnostics is a UK-based private limited company that operates as an exclusive distributor of point-of-care diagnostic solutions for the United Kingdom and Ireland markets. The company distributes three flagship analysers: HemoScreen (a 5-minute point-of-care Full Blood Count analyser from PixCell Medical using disposable cartridges), MyCare INSITE (a sub-7-minute antipsychotic drug monitoring analyser from Saladax Biomedical covering clozapine, aripiprazole, risperidone/paliperidone, quetiapine, and olanzapine), and Piccolo Xpress (a clinical chemistry analyser offering 31 specific tests and 17 chemistry panels within 12 minutes). The Cartridge-based architecture of the HemoScreen and MyCare INSITE products eliminates calibration and maintenance requirements and produces a recurring consumables revenue stream on top of equipment placement.

Katalyst was formed in 2020 as a division of Katalyst Laboratories and serves NHS trusts, mental health services, and public healthcare organisations across the UK and Ireland. Documented customers include Oxford Health NHS Foundation Trust, Norfolk and Norwich University Hospitals NHS Foundation Trust, Mersey Care NHS Foundation Trust, Guy's and St Thomas' NHS Foundation Trust, Devon Partnership NHS Trust, South London and Maudsley NHS Foundation Trust, Bradford District Care NHS Foundation Trust, and North East London NHS Foundation Trust. The company is led by co-founder and CEO Andrew Wheeler and operates from London.

The business model is a sales-led, direct distribution model targeting NHS procurement and clinical departments, with revenue generated through hardware sales of diagnostic analysers and recurring consumables (disposable cartridges and test panels). Go-to-market is concentrated in industry exhibitions such as the IBMS Congress and the POCT Innovations Conference, complemented by direct engagement with healthcare procurement and NHS framework contracts. The company does not appear to develop proprietary diagnostic technology; its value proposition rests on the exclusivity of its distribution rights and the clinical performance of the underlying manufacturer products.

Name

Katalyst Diagnostics

Legal name

Katalyst Diagnostics Ltd

Website

https://katalystdiagnostics.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Katalyst Diagnostics is the exclusive UK and Ireland distributor of point-of-care diagnostic analysers (HemoScreen, MyCare INSITE, Piccolo Xpress), supplying NHS trusts and healthcare organisations with rapid haematology, clinical chemistry, and antipsychotic drug monitoring testing solutions.

Ownership category

akta.pro rank

Product category

Point-of-Care Diagnostics

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels) (HLAHAOAG)

akta.pro secondary industry

Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI)

Keywords

• Point-of-care diagnostics
• Haematology analysers
• Clinical chemistry testing
• Antipsychotic drug monitoring
• Healthcare distribution

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Diagnostic Equipment Distribution: Distribution of point-of-care diagnostic analysers (HemoScreen, MyCare INSITE, Piccolo Xpress) and associated consumables (disposable cartridges) to NHS and healthcare organizations across UK and Ireland.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Katalyst Diagnostics is the exclusive UK and Ireland distributor of three point-of-care diagnostic analyzers for NHS trusts and healthcare organisations: the HemoScreen FBC analyser (full blood counts in 5 minutes), the MyCare INSITE (antipsychotic drug monitoring in under 7 minutes), and the Piccolo Xpress (clinical chemistry panels in 12 minutes), along with their proprietary disposable cartridges. The portfolio targets emergency, oncology, ambulatory, paediatric, and mental health care pathways where rapid lab-quality results support faster clinical decisions.

Product overview

Katalyst Diagnostics provides a portfolio of three point-of-care diagnostic analysers: HemoScreen™ (haematology/CBC testing with results in 5 minutes), MyCare INSITE™ (antipsychotic drug monitoring with results in <7 minutes), and Piccolo Xpress® (clinical chemistry with results in 12 minutes). The company operates as a distributor, serving NHS and healthcare organisations across the UK & Ireland, and is the exclusive UK distributor for HemoScreen™ FBC Analyser.

Differentiator

Problem solved

Functional benefit

Products and services

• HemoScreen FBC Analyser The world's first and only true point-of-care Full Blood Count analyser offering laboratory-quality results within 5 minutes from a single finger-prick of blood; uses patented disposable cartridges preloaded with reagents, requires no maintenance or calibration, and provides CBC plus comprehensive abnormal cell flagging for NHS use in emergency, oncology, and ambulatory care.
• MyCare INSITE Antipsychotic Drug Analyser The only point-of-care analyser that measures the most commonly prescribed antipsychotic drugs, including Clozapine, Risperidone/Paliperidone, Quetiapine, Olanzapine, and Total Aripiprazole, delivering results in less than 7 minutes from a drop of blood; supports mental health pathways in distinguishing treatment resistance from adherence issues.
• Piccolo Xpress Clinical Chemistry Analyser Point-of-care clinical chemistry analyser providing laboratory-quality results within 12 minutes with 31 specific tests and 17 complete chemistry panels, trusted for over 30 years; supports diabetes, cholesterol, kidney, liver, and other biomarker testing at the point of care for NHS and healthcare organisations.

Quantifiable outcome

• Lab-quality results within 5 minutes for CBC testing (vs. traditional laboratory turnaround of hours to days)
• +2 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• PixCell MedicalflagshipChannel Partner/ Reseller/ DistributorExclusive distribution agreement signed for Katalyst Diagnostics to distribute PixCell's HemoScreen FBC analyser across the United Kingdom and Ireland. HemoScreen is the world's first portable, plug-and-play, 5-part differential haematology analyser offering lab quality results within 5 minutes from a single finger-prick of blood. The analyser is FDA-cleared, CE-marked, and TGA-approved for point-of-care use. Katalyst Diagnostics serves as the sole UK distributor for this flagship product.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• QuidelOrtho: Rapid diagnostics company spanning immunoassay, molecular, and POC testing with established hospital and clinical-lab channels. Comparable buyer segment (clinical labs, hospitals) and POC cartridge-based business model.
• Randox: UK- and Ireland-based diagnostics company with POC clinical chemistry and immunoassay platforms plus a broader lab-testing portfolio. Operates in the same geographies and competes for NHS POC business, but at much greater scale and breadth.
• Abbott Point of Care: i-STAT POC blood analyser franchise from Abbott, widely deployed across NHS trusts. Overlaps with Katalyst's HemoScreen and Piccolo Xpress in emergency, ambulatory, and hospital POC settings, though part of a much larger diagnostics portfolio.
• Siemens Healthineers: Global diagnostics giant with POC blood gas, chemistry, and immunoassay systems (epoc, RAPIDPoint) sold into NHS hospitals. Competes on POC clinical chemistry and haematology workflows but at enterprise scale.
• Roche Diagnostics: Operates cobas POC and other near-patient testing platforms sold into NHS trusts and reference labs. Overlaps with Katalyst on clinical chemistry and broader POC menu, but as one segment within a global diagnostics franchise.

Direct peers

• Radiometer: POC blood-gas and immunoassay analyser company serving hospitals and clinical labs worldwide. Comparable cartridge-based POC model and similar acute-care NHS buyer segment, especially for emergency and ambulatory settings.
• HORIBA Medical: Clinical chemistry and haematology POC instrument manufacturer with a 30-year installed base comparable to Piccolo Xpress. Overlaps on the clinical-chemistry POC category Katalyst distributes and shares similar NHS/hospital procurement pathways.
• Nova Biomedical: Manufacturer of POC blood gas, chemistry, and haematology analysers used in hospital and critical-care settings. Directly comparable product modality (POC blood analysis with cartridge consumables) and similar clinical buyers in emergency and ambulatory care.
• EKF Diagnostics Holdings: Wales-based diagnostics company selling point-of-care haematology, chemistry, and diabetes testing devices globally. Closest UK-headquartered POC peer with overlapping product categories (haematology, clinical chemistry) and similar B2B distribution into healthcare providers.

Others

• PixCell Medical: Israeli developer and manufacturer of the HemoScreen POC FBC analyser distributed exclusively by Katalyst in the UK and Ireland. Included as an ecosystem partner rather than a competitor — the upstream supplier whose commercial relationship defines Katalyst's flagship product line.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/katalyst-diagnostics

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Katalyst Diagnostics